S04 E06: Driving access to all medicines
EMJ GOLD: Pharma news, views and analysis
00:00
Generics and Diabetes: What's Next for the Foundation?
Last year we published our new strategic direction. So as part of that direction, we are expanding the scope of our work to other industries. The insulin manufacturing market is very concentrated. We have three companies that lead the market in LMICs both on the manufacturing and supply sites. It's really important for us to understand how these companies are performing when it comes to access to insulin.
Play episode from 04:58
Transcript
